Theranos reportedly settles $140M Walgreens suit for less than $30M

Ars Technica ----- Theranos told its investors that it has reached a tentative settlement with former business partner Walgreens and will pay out less than $30 million in the agreement, The Wall Street Journal reports. The drugstore giant filed a searing lawsuit late last year against the beleaguered blood-testing company. Walgreens was seeking $140 million—presumed to be the amount it invested in a 2012 deal with Theranos to host blood-testing ‘Wellness Centers’ in its stores. In court filings, Walgreens alleged that Theranos had broken all its promises and “failed to meet the most basic quality standards and legal requirements” of their partnership. To learn more click on the picture below to read the article.